Oligonucleotides have rapidly gained momentum as a class of biotherapeutics presenting complex challenges in the commercialization of gene therapies. Learn how our unique platform can help you rapidly propel through the development process.
WATCH OUR WEBINAR
EXPERIENCE MATTERS
In the rapidly developing field of gene therapy, Pace® is considered an experienced veteran. Since 2015 we have worked closely with our customer-partners to accelerate processes and provide support throughout the gene therapy product development cycle.
PACE Pharmaceutical & Biopharmaceutical Product Development
